Unveiling therapeutic prospects: targeting MDM-2 in non-muscle invasive bladder cancer

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1-2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Bell, J. A., Cao, Y., Gunn, J. R., Day, T., Gallicchio, E., Zhou, Z., et al. (2012). PrimeX and the Schrödinger computational chemistry suite of programs(pp. 534–538).
   Google Scholar
• Cai, Z., Zhang, F., Chen, W., Zhang, J., & Li, H. (2019). Mirnas: A promising target in the chemoresistance of bladder cancer. OncoTargets and Therapy, 12, 11805–11816. https://doi.org/10.2147/OTT.S231489
   PubMed Web of Science ®Google Scholar
• Cancer Index. (1996). National and international cancer organisations. CancerIndex. Available from: http://www.cancerindex.org/clinks7.htm
   Google Scholar
• Dallakyan, S., & Olson, A. J. (2015). Small-molecule library screening by docking with PyRx. Methods in Molecular Biology (Clifton, N.J.), 1263, 243–250. https://doi.org/10.1007/978-1-4939-2269-7_19
   PubMedGoogle Scholar
• Eberhardt, J., Santos-Martins, D., Tillack, A. F., & Forli, S. (2021). AutoDock Vina 1.2.0: New docking methods, expanded force field, and python bindings. Journal of Chemical Information and Modeling, 61(8), 3891–3898. https://doi.org/10.1021/acs.jcim.1c00203
   PubMed Web of Science ®Google Scholar
• Gómez-Rubio, V. (2017). ggplot2 - Elegant graphics for data analysis (2nd Edition). Journal of Statistical Software, 77(2), 1-3. https://doi.org/10.18637/jss.v077.b02
   PubMedGoogle Scholar
• Huang, J., & Mackerell, A. D. (2013). CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR data. Journal of Computational Chemistry, 34(25), 2135–2145. https://doi.org/10.1002/jcc.23354
   PubMed Web of Science ®Google Scholar
• Khoutoul, M., Djedouani, A., Lamsayah, M., Abrigach, F., & Touzani, R. (2016). Liquid-liquid extraction of metal ions, DFT and TD-DFT analysis for some pyrane derivatives with high selectivity for Fe(II) and Pb(II). Separation Science and Technology. 51(7), 1112–1123. https://doi.org/10.1080/01496395.2015.1107583
   Web of Science ®Google Scholar
• Kim, D., Paggi, J. M., Park, C., Bennett, C., & Salzberg, S. L. (2019). Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nature Biotechnology, 37(8), 907–915. https://doi.org/10.1038/s41587-019-0201-4
   PubMed Web of Science ®Google Scholar
• Li, H.-J., Gong, X., Li, Z.-K., Qin, W., He, C.-X., Xing, L., Zhou, X., Zhao, D., & Cao, H.-L. (2021). Role of long non-coding RNAs on bladder cancer. Frontiers in Cell and Developmental Biology, 9, 672679. https://doi.org/10.3389/fcell.2021.672679
   PubMedGoogle Scholar
• Li, Y., Sun, L., Guo, X., Mo, N., Zhang, J., & Li, C. (2021). Frontiers in Bladder cancer genomic research. Frontiers in Oncology, 11, 670729. https://doi.org/10.3389/fonc.2021.670729
   PubMed Web of Science ®Google Scholar
• Mark, P., & Nilsson, L. (2001). Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. The Journal of Physical Chemistry A, 105(43), 9954–9960. https://doi.org/10.1021/jp003020w
   Web of Science ®Google Scholar
• Martin-Doyle, W., & Kwiatkowski, D. J. (2015). Molecular biology of bladder cancer. Hematology/Oncology Clinics of North America, 29(2), 191–203, vii. https://doi.org/10.1016/j.hoc.2014.10.002
   PubMed Web of Science ®Google Scholar
• Mendoza, M., Mandani, G., & Momand, J. (2014). The MDM2 gene family. Biomolecular Concepts, 5(1), 9–19. https://doi.org/10.1515/bmc-2013-0027
   PubMedGoogle Scholar
• Mokou, M., Lygirou, V., Angelioudaki, I., Paschalidis, N., Stroggilos, R., Frantzi, M., Latosinska, A., Bamias, A., Hoffmann, M. J., Mischak, H., & Vlahou, A. (2020). A novel pipeline for drug repurposing for bladder cancer based on patients’ omics signatures. Cancers, 12(12), 3519. https://doi.org/10.3390/cancers12123519
   PubMed Web of Science ®Google Scholar
• Munisamy, M., Mukherjee, N., Thomas, L., Pham, A. T., Shakeri, A., & Zhao, Y. (2021). Therapeutic opportunities in cancer therapy: Targeting the p53-MDM2/MDMX interactions. American Journal of Cancer Research, 11(12), 5762–5781.
   PubMed Web of Science ®Google Scholar
• Oyedele, A.-Q K., Adelusi, T. I., Ogunlana, A. T., Adeyemi, R. O., Atanda, O. E., Babalola, M. O., Ashiru, M. A., Ayoola, I. J., & Boyenle, I. D. (2022). Integrated virtual screening and molecular dynamics simulation revealed promising drug candidates of p53-MDM2 interaction. Journal of Molecular Modeling, 28(6), 142. https://doi.org/10.1007/s00894-022-05131-w
   PubMed Web of Science ®Google Scholar
• Pertea, M., Kim, D., Pertea, G. M., Leek, J. T., & Salzberg, S. L. (2016). Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nature Protocols, 11(9), 1650–1667. https://doi.org/10.1038/nprot.2016-095
   PubMed Web of Science ®Google Scholar
• Pertea, M., Pertea, G. M., Antonescu, C. M., Chang, T. C., Mendell, J. T., & Salzberg, S. L. (2015). StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nature Biotechnology, 33(3), 290–295. https://doi.org/10.1038/nbt.3122
   PubMed Web of Science ®Google Scholar
• Shaheen, M. F., Segar, J. M., Chmielowski, B., Drabick, J. J., McKean, M., Reeves, J. A., Karapetis, C. S., Orloff, M. M., Tolcher, A. W., Beck, J. T. T., Gastman, B., De, A., Paudyal, B., Winkler, R. E., Li, M., Ahmad, M., Yang, D., & Zhai, Y. (2023). A phase 2 study of alrizomadlin (APG-115) in combination with pembrolizumab in patients with unresectable or metastatic cutaneous melanoma that has failed immuno-oncologic (IO) drugs. Journal of Clinical Oncology, 41(16_suppl), 9559–9559. https://doi.org/10.1200/JCO.2023.41.16_suppl.9559
   Web of Science ®Google Scholar
• Shaweta, S., Akhil, S., & Utsav, G. (2021). Molecular docking studies on the anti-fungal activity of Allium sativum (Garlic) against Mucormycosis (black fungus) by BIOVIA discovery studio visualizer 21.1.0.0. Annals of Antivirals and Antiretrovirals, 5(1), 28–32. https://doi.org/10.17352/aaa.000013
   Google Scholar
• Somaiah, N., Van Tine, B. A., Chmielowski, B., Drabick, J. J., Chawla, S. P., McKean, M., Spira, A. I., O'Byrne, K. J., Foresto, S. A., Movva, S., Kim, A., Gastman, B., Pressey, J. G., Paudyal, B., De, A., Winkler, R. E., Li, M., Ahmad, M., Yang, D., & Zhai, Y. (2023). A phase 2 study of alrizomadlin, a novel MDM2/p53 inhibitor, in combination with pembrolizumab for treatment of patients with malignant peripheral nerve sheath tumor (MPNST). Journal of Clinical Oncology, 41(16_suppl), e14627–e14627. https://doi.org/10.1200/JCO.2023.41.16_suppl.e14627
   Web of Science ®Google Scholar
• Steinberg, R. L., Thomas, L. J., & O'Donnell, M. A. (2018). Combination intravesical chemotherapy for non–muscle-invasive bladder cancer. European Urology Focus, 4(4), 503–505. https://doi.org/10.1016/j.euf.2018.07.005
   PubMedGoogle Scholar
• Tran, L., Xiao, J. F., Agarwal, N., Duex, J. E., & Theodorescu, D. (2021). Advances in bladder cancer biology and therapy. Nature Reviews. Cancer, 21(2), 104–121. https://doi.org/10.1038/s41568-020-00313-1
   PubMed Web of Science ®Google Scholar
• Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., Darian, E., Guvench, O., Lopes, P., Vorobyov, I., & Mackerell, A. D. (2010). CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. Journal of Computational Chemistry, 31(4), 671–690. https://doi.org/10.1002/jcc.21367
   PubMed Web of Science ®Google Scholar
• Wickham, H., Averick, M., Bryan, J., Chang, W., McGowan, L., François, R., Grolemund, G., Hayes, A., Henry, L., Hester, J., Kuhn, M., Pedersen, T., Miller, E., Bache, S., Müller, K., Ooms, J., Robinson, D., Seidel, D., Spinu, V., … Yutani, H. (2019). Welcome to the tidyverse. Journal of Open Source Software, 4(43), 1686. https://doi.org/10.21105/joss.01686
   Google Scholar
• Zhao, Y., Yu, H., & Hu, W. (2014). The regulation of MDM2 oncogene and its impact on human cancers. Acta Biochimica et Biophysica Sinica, 46(3), 180–189. https://doi.org/10.1093/abbs/gmt147
   PubMed Web of Science ®Google Scholar